A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis

Clinical trial NCT07529925 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07529925
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Severe Plaque Psoriasis in Chinese Children

Start date: 2026-05-01
Primary completion: 2028-04-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.